Estrogenic activity is increased for an antiestrogen by a natural mutation of the estrogen receptor

This publication has 16 references indexed in Scilit:

• An analysis of tamoxifen-stimulated human carcinomas for mutations in the AF-2 region of the estrogen receptor
  The Journal of Steroid Biochemistry and Molecular Biology, 1996
• Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens
  Molecular Endocrinology, 1996
• A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog
  Molecular Endocrinology, 1995
• Comparison of the Effects of a Pure Steroidal antiestrogen With Those of Tamoxifen in a Model of Human Breast Cancer
  JNCI Journal of the National Cancer Institute, 1995
• Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines
  The Journal of Steroid Biochemistry and Molecular Biology, 1994
• Paradoxical regulation of estrogen-dependent growth factor gene expression in estrogen receptor (ER)-negative human breast cancer cells stably expressing ER
  Cancer Letters, 1994
• Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.
  Journal of Clinical Investigation, 1994
• Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice
  Breast Cancer Research and Treatment, 1994
• The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain
  Breast Cancer Research and Treatment, 1994
• A simple, rapid, and sensitive DNA assay procedure
  Analytical Biochemistry, 1980